Insider Transactions in Q2 2020 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2020
|
Wendall Wierenga |
BUY
Exercise of conversion of derivative security
|
Direct |
25,329
+20.23%
|
$0
$0.73 P/Share
|
|
Apr 17
2020
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,071,428
+22.65%
|
$14,999,992
$14.0 P/Share
|
|
Apr 17
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
84,598
-3.32%
|
$1,268,970
$15.4 P/Share
|
|
Apr 16
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,190
-1.17%
|
$452,850
$15.2 P/Share
|
|
Apr 15
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
215,810
-7.73%
|
$3,237,150
$15.5 P/Share
|
|
Apr 07
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,115
-0.22%
|
$85,610
$14.2 P/Share
|
|
Apr 03
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300,000
-9.68%
|
$3,900,000
$13.8 P/Share
|